Stay updated with breaking news from Pascal Touchon. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Shares of Atara Biotherapeutics, Inc. (NASDAQ:ATRA – Free Report) have been assigned a consensus recommendation of “Hold” from the seven analysts that are presently covering the stock, Marketbeat.com reports. Two investment analysts have rated the stock with a sell recommendation, two have issued a hold recommendation and three have assigned a buy recommendation to the […]
HC Wainwright reiterated their buy rating on shares of Atara Biotherapeutics (NASDAQ:ATRA – Get Rating) in a report published on Wednesday, The Fly reports. HC Wainwright currently has a $28.00 price target on the biotechnology company’s stock, up from their previous price target of $27.00. HC Wainwright also issued estimates for Atara Biotherapeutics’ Q2 2023 […]
Atara Biotherapeutics, Inc. (NASDAQ:ATRA – Get Rating) was the target of a significant drop in short interest during the month of May. As of May 31st, there was short interest totalling 12,620,000 shares, a drop of 11.0% from the May 15th total of 14,180,000 shares. Based on an average daily volume of 1,660,000 shares, the […]
HC Wainwright reiterated their buy rating on shares of Atara Biotherapeutics (NASDAQ:ATRA – Get Rating) in a report published on Wednesday morning, The Fly reports. HC Wainwright currently has a $28.00 price target on the biotechnology company’s stock, up from their prior price target of $27.00. HC Wainwright also issued estimates for Atara Biotherapeutics’ Q2 […]
Atara Biotherapeutics, Inc. (NASDAQ:ATRA – Get Rating) was the target of a large decrease in short interest in May. As of May 31st, there was short interest totalling 12,620,000 shares, a decrease of 11.0% from the May 15th total of 14,180,000 shares. Based on an average daily volume of 1,660,000 shares, the days-to-cover ratio is […]